Molecular subtypes of pancreatic cancer

Collisson, Eric A., Bailey, Peter, Chang, David K., Biankin, Andrew V.·2019·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/s41575-019-0109-y

Cited by (895)

Items 301–400 of 895

Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma
Shikha Roy, A. Singh, D. Gupta · 2021 · Heliyon
Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies
Jimmy A. Guo, Hannah I. Hoffman, Colin D. Weekes, Lei Zheng, David Tsai Ting, William L. Hwang · 2021 · Clinical Cancer Research
Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
Qiyao Zhang, Zhihui Wang, Xiao Yu, Menggang Zhang, Qingyuan Zheng, Yuting He, Wenzhi Guo · 2021 · Frontiers in Cell and Developmental Biology
Loss of FGFR4 promotes the malignant phenotype of PDAC
Sabrina L. D’Agosto, Francesco Pezzini, Lisa Veghini, Pietro Delfino, Claudia Fiorini, Gael D. Temgue Tane, Anais Del Curatolo, Caterina Vicentini, Giorgia Ferrari, Davide Pasini et al. · 2022 · Oncogene
A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer
Susanna W.L. de Geus, Teviah Erik Sachs · 2023 · Annals of Surgical Oncology
It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease
Amelia Cephas, William L. Hwang, Anirban Maitra, Oren Parnas, Kathleen E. DelGiorno · 2023 · Gut
Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer
Zhaokai Zhou, Yuyuan Zhang, Jing Li, Siyuan Weng, Jie Li, Shuang Chen, Jinxiang Lv, Nuo Xu, Yanping Zhang, Shuai Yang et al. · 2023 · Cellular Signalling
Emerging Prognostic and Predictive Factors in Pancreatic Cancer
Eva Karamitopoulou · 2023 · Modern Pathology
Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer
Xi Zoë Zhong, Xiaoxue Ke, Yang He, Xiang Ye, Can Li, Jun Pan, Wenhao Ran, Feng Wang, Hongjuan Cui · 2024 · Phytomedicine
The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing
Nabeel Merali, Tarak Agrebi Moumni Chouari, Casie Sweeney, James Michael Halle-Smith, Maria-Danae Jessel, Bing Wang, James O Brien, Satoshi Suyama, José Ignacio Jiménez, Keith John Roberts et al. · 2024 · International Journal of Surgery
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, Venu Gopal Pillarisetty, Danting Li, Chaohui L. Zhao, Suparna A. Sarkar, Weiguo Liu, Iman T. Hanna, Mala R. Gupta et al. · 2025 · npj Precision Oncology
Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer
Dehua Zhou, Di Mu, Ming Y. Cheng, Yuting Dou, Xianwei Zhang, Zhensheng Feng, Guangting Qiu, Hua Yu, Yang Chen, Hong Xu et al. · 2020 · Acta Cirúrgica Brasileira
Identifying Cancer Patient Subgroups by Finding Co-Modules From the Driver Mutation Profiles and Downstream Gene Expression Profiles
Junrong Song, Wei Peng, Feng Wang · 2021 · IEEE Transactions on Computational Biology and Bioinformatics
Models of pancreatic ductal adenocarcinoma
Rayane Dennaoui, Hridaya Shrestha, Kay-Uwe Wagner · 2021 · Cancer Metastasis Review
Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
Xinyang Huang, Liangchao Zhao, Yixun Jin, Zhuoxin Wang, Tong Li, Hui Xu, Qi Wang, Lifu Wang · 2022 · Frontiers in Oncology
Treatment of pancreatic cancer in 2022
Raffaella Casolino, Andrew Victor Biankin · 2023 · Cambridge Prisms Precision Medicine
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
Li-Yun Ding, Ya‐Chin Hou, I‐Ying Kuo, Ting-Yi Hsu, Tsung-Ching Tsai, Hsiu-Wei Chang, Wei-Yu Hsu, Chih-Chieh Tsao, Chung-Chen Tian, Po‐Shun Wang et al. · 2020 · Clinical Epigenetics
Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
James W. Sinnett‐Smith, Tarique Anwar, Elaine F. Reed, Yaroslav Teper, Guido Eibl, Enrique Rozengurt · 2022 · Molecular Cancer Therapeutics
Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer
Wenkai Jiang, Yan Du, Wenlong Zhang, Wence Zhou · 2022 · Canadian Journal of Gastroenterology and Hepatology
HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1
Renpeng Xia, Chonghui Hu, Yuancheng Ye, Xiang Zhang, Tingting Li, Rihua He, Shangyou Zheng, Xiaofeng Wen, Rufu Chen · 2023 · International Journal of Oncology
In vivo models of pancreatic ductal adenocarcinoma
Vignesh Vudatha, Kelly M. Herremans, Devon C. Freudenberger, Christopher Liu, Jose Trevino · 2023 · Advances in cancer research
A Novel HOXA10 -Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
Sophia G. Kisling, Pranita Atri, Ashu Shah, Jesse L. Cox, Sunandini Sharma, Lynette M. Smith, Dario Ghersi, Surinder K. Batra · 2023 · Clinical Cancer Research
Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma
Xing Wang, Jinshou Yang, Bo Ren, Gang Yang, Xiaohong Liu, Ruiling Xiao, Jie Ren, Feihan Zhou, Lei You, Yupei Zhao · 2023 · Genes & Diseases
Prolonged HPA axis dysregulation in postpartum depression associated with adverse early life experiences: a cross-species translational study
Minae Niwa, Sedona Lockhart, Daniel J. Wood, Kun Yang, José Fernando de Oliveira, Kyohei Kin, Adeel Ahmed, Gary S. Wand, Shin‐ichi Kano, Jennifer L. Payne et al. · 2024 · Nature Mental Health
Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors
Jiawei Fan, Jianshu Zhu, He Zhu, Hong Xu · 2024 · Critical Reviews in Oncology/Hematology
Immunological and functional aspects of MAGEA3 cancer/testis antigen
Biswajit Das, Shantibhusan Senapati · 2020 · Advances in protein chemistry and structural biology
Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer
Jung Yong Hong, Hee Jin Cho, Seung Tae Kim, Young Suk Park, Sang Hyun Shin, In Woong Han, Jeeyun Lee, Jin Seok Heo, Joon Oh Park · 2021 · Therapeutic Advances in Medical Oncology
Steroidal saponins PPI/CCRIS/PSV induce cell death in pancreatic cancer cell through GSDME-dependent pyroptosis
Yang Liu, Weitao Zhang, Haoyan Zhou, Jun Chen · 2023 · Biochemical and Biophysical Research Communications
A Clinically Applicable 24-Protein Model for Classifying Risk Subgroups in Pancreatic Ductal Adenocarcinomas using Multiple Reaction Monitoring-Mass Spectrometry
Minsoo Son, Hongbeom Kim, Dohyun Han, Yoseop Kim, Iksoo Huh, Youngmin Han, Seung‐Mo Hong, Wooil Kwon, Haeryoung Kim, Jin‐Young Jang et al. · 2021 · Clinical Cancer Research
Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
Peinan Liu, Juliette Jacques, Chang‐Il Hwang · 2024 · Epigenomes
The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
Jorge Meléndez-Zajgla, Vilma Maldonado · 2021 · International Journal of Molecular Sciences
Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer
Mohammad Azhar Kamal, Imran Siddiqui, Cristina Belgiovine, Marialuisa Barbagallo, Valentina Paleari, Daniela Pistillo, Chiara Chiabrando, Silvia Schiarea, Barbara Bottazzi, Roberto Leone et al. · 2022 · Cancers
A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
Nan Wei, Gong Chao-yang, Wenming Zhou, Lei Ze-yuan, Yongqiang Shi, Zhang Shun-bai, Zhang Kai, Ma Yan-chao, Hai-Hong Zhang · 2022 · Frontiers in Pharmacology
Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer
Duancheng Guo, Long‐Yun Ye, Weiding Wu, Xianjun Yu, Kaizhou Jin · 2023 · Acta Biochimica et Biophysica Sinica
Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma
Carlos Lopez-Blazquez, Carlos Lacalle-González, Lara Sanz-Criado, Michael Ochieng’ Otieno, Jesús García‐Foncillas, Javier Martínez‐Useros · 2023 · International Journal of Molecular Sciences
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi · 2024 · Cancers
Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai · 2024 · Cells
Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples
Warapen Treekitkarnmongkol, Jianliang Dai, Suyu Liu, Deivendran Sankaran, Tristian Nguyen, Seetharaman Balasenthil, Mark W. Hurd, Meng Chen, Hiroshi Katayama, Sinchita Roy‐Chowdhuri et al. · 2024 · Gastro Hep Advances
Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
Julia R. Naso, James Thomas Topham, Joanna M. Karasinska, Michael K.C. Lee, Steve E. Kalloger, Hui‐Li Wong, Jessica Nelson, Richard A. Moore, Andrew J. J. Mungall, Steven J.M. Jones et al. · 2020 · Cancer Medicine
miR-373 Suppresses Cell Proliferation and Apoptosis via Regulation of SIRT1/PGC-1α/NRF2 Axis in Pancreatic Cancer.
Qinghua Yin, Yuan Zhou, Z Hi Yuan Li · 2021 · PubMed Central
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
Inês Faleiro, Vânia Palma Roberto, Seçil Demirkol Canlı, Nicolas Alejandro Fraunhoffer, Juan Iovanna, Ali Osmay Gure, Wolfgang Link, Pedro Castelo‐Branco · 2021 · Cancers
Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification
Yi Chen, Didi Chen, Qiang Wang, Yajing Xu, Xiaowei Huang, Felix Haglund, Huafang Su · 2022 · Frontiers in Immunology
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells
Michele Simbolo, Nicola Silvestris, Giuseppe Malleo, Andrea Mafficini, Laura Maggino, Alessandra Cocomazzi, Lisa Veghini, Aldo Mombello, Francesco Pezzini, Elisabetta Sereni et al. · 2023 · Modern Pathology
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo
Francesca Lupo, Geny Piro, Lorena Torroni, Pietro Delfino, Rosalinda Trovato, Borislav Chavdarov Rusev, Alessandra Fiore, Dea Filippini, Francesco De Sanctis, Marcello Manfredi et al. · 2020 · Frontiers in Cell and Developmental Biology
Pathology and Molecular Characteristics of Pancreatic Cancer
Joseph F. Kearney, Volkan N. Adsay, Jen Jen Yeh · 2021 · Surgical Oncology Clinics of North America
Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Antero Puolakkainen, Sakari Knuutila · 2022 · Biomolecules
Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma
Sangyeop Hyun, Daechan Park · 2022 · Computational and Structural Biotechnology Journal
Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
Prashanth Ashok Kumar, Serenella Serinelli, Daniel J. Zaccarini, Richard S.P. Huang, Natalie A. Danziger, Tyler Janovitz, Alina Basnet, Abirami Sivapiragasam, Stephen L. Graziano, Jeffrey S. Ross · 2023 · Frontiers in Oncology
The genomic and immunogenomic landscape of mechanics pathway informs clinical prognosis and response to mechanotherapy
Peidong Zhang, Peiwei Li, Muya Tang, Ryan C. Gimple, Liang Huang, Jing Yue, Qiuhong Shen, Yiwei Du, Qian Zhang, Zhengnan Yang et al. · 2024 · Science China Life Sciences
Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer
Chiara Naro, Veronica Ruta, Claudio Sette · 2024 · Trends in Molecular Medicine
Transportome Malfunctions and the Hallmarks of Pancreatic Cancer
Qi Ling, Holger Kalthoff · 2020 · Reviews of physiology, biochemistry and pharmacology
The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer
Zainab Hussain, Jérémy Nigri, Richard Tomasini · 2021 · Cancers
Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?
Dale M. Watt, Jennifer P. Morton · 2021 · Cancers
Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
Xiaoyan Yang, Yuan‐Fei Lu, Jianxia Xu, Yongzhong Du, Ri‐Sheng Yu · 2023 · Molecules
Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature
Qiang Li, Tienan Feng, Tengteng Zhu, Weituo Zhang, Ying Qian, Huan Zhang, Xiangqian Zheng, Dapeng Li, Xinwei Yun, Jingzhu Zhao et al. · 2023 · Journal of Translational Medicine
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project
Alexander Semaan, Vincent Bernard, Justin Wong, Yuki Makino, Daniel B. Swartzlander, Kimal Rajapakshe, Jaewon James Lee, Adam Officer, Christian Max Schmidt, Howard Her‐Juing Wu et al. · 2023 · Cancer Research Communications
A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activators against pancreatic cancer
Yang Liu, Xiaowei Zhang, Ping Zhang, Tingting He, Weitao Zhang, Dingyuan Ma, Ping Li, Jun Chen · 2023 · Acta Pharmaceutica Sinica B
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
Andrea Vallés‐Martí, Richard R. de Goeij‐de Haas, Alex A. Henneman, Sander R. Piersma, Thang V. Pham, Jaco C. Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti et al. · 2024 · Molecular Oncology
Contemporary Approaches to Immunotherapy of Solid Tumors
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, Белецкий Игорь Петрович, Ivanov Aa · 2024 · Cancers
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer
Paloma Moreno, Yuuki Ohara, Amanda J. Craig, Huaitian Liu, S. S. Yang, Tiffany H. Dorsey, Lin Zhang, Gatikrushna Panigrahi, Helen Cawley, Azadeh Azizian et al. · 2024 · Carcinogenesis
Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models
Seçil Ak Aksoy, Julie Earl, Jelena Grahovac, Didem Karakaş, Giulia Lencioni, Sıla Sığırlı, Maarten F. Bijlsma · 2024 · Seminars in Cancer Biology
Multiomics integrative analysis for gene signatures and prognostic values of m6A regulators in pancreatic adenocarcinoma: a retrospective study in The Cancer Genome Atlas project
Wenzhe Gao, Liuyang Cheng, Shuhan He, Wei Li, Chengyu Zhou, Bixia Zhou, Jiamiao Liu, Jiahao Xu, Xiao Yu, Hongwei Zhu · 2020 · Aging
Silencing of long non‑coding RNA SNHG15 suppresses proliferation, migration and invasion of pancreatic cancer cells by regulating the microRNA‑345‑5p/RAB27B axis
Pengfei Jiang, Youmin Yin, Yan Wu, Zhaoli Sun · 2021 · Experimental and Therapeutic Medicine · Retracted
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, Raquel Blanco Martínez-Illescas, Ángela Pastor Senovilla, Marian Lozano Yagüe, Alfonsina Trento, Rosa García-Martín, Diego Navarro, Bruno Sáinz et al. · 2022 · Cancers
Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information
Xin Li, Xuan Zhang, Xiangyu Lin, Liting Cai, Yan Wang, Zhiqiang Chang · 2022 · Genes
Epithelial to Mesenchymal Transition as Mechanism of Progression of Pancreatic Cancer: From Mice to Men
Luana Greco, Federica Rubbino, Luigi Laghi · 2022 · Cancers
Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota
Catalina M. Perelló-Reus, Teresa Rubio‐Tomás, Eugenia Cisneros Barroso, Lesly Ibargüen-González, Juan José Segura‐Sampedro, Rafael Morales-Soriano, Carles Barceló · 2022 · Frontiers in Oncology
The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma
Victoria Heredia-Soto, Laura Gutiérrez-Sainz, Ismael Ghanem, Laura Guerra, Elena Palacios, Marta de Uribe, Lucía Trilla‐Fuertes, María de Miguel, Paloma Cejas, Laura Medina et al. · 2023 · Biomedicines
RON receptor tyrosine kinase in pancreatic ductal adenocarcinoma: Pathogenic mechanism in malignancy and pharmaceutical target for therapy
Hangping Yao, Rachel Hudson, Ming‐Hai Wang · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The recurring features of molecular subtypes in distinct gastrointestinal malignancies—A systematic review
R. Adam, Ilse Blomberg, Sanne ten Hoorn, Maarten F. Bijlsma, Louis Vermeulen · 2021 · Critical Reviews in Oncology/Hematology
Inhibition of TRIM32 by ibr‐7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway
Bo Zhang, Youyou Yan, Yang‐qin Gu, Fei Teng, Lin Xu, Xinglu Zhou, Jinxin Che, Xiaowu Dong, Lixin Zhou, Neng‐ming Lin · 2021 · Journal of Cellular and Molecular Medicine
RETRACTED ARTICLE: ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis
Xiaohao Zheng, Yongxing Du, Mingyang Liu, Chengfeng Wang · 2023 · Functional & Integrative Genomics · Retracted
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Huaitian Liu, Amanda J. Craig, Shouhui Yang, Paloma Moreno, Tiffany H. Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael B. Ghadimi et al. · 2024 · International Journal of Cancer
The scRNA-sequencing landscape of pancreatic ductal adenocarcinoma revealed distinct cell populations associated with tumor initiation and progression
Ying Wang, Zhouliang Bian, Lichao Xu, Guangye Du, Zihao Qi, Yanjie Zhang, Jiang Long, Wentao Li · 2024 · Genes & Diseases
GATA6 in pancreatic cancer initiation and progression
Muyuan Ma, Jianhong An, Tingting Jiang, Keping Xie · 2024 · Genes & Diseases
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives
Ari Hashimoto, Shigeru Hashimoto · 2024 · Cancers
Primary and metastatic cellular landscapes in human pancreatic cancer
Nina G. Steele, Veerin R. Sirihorachai, Ahmed M. Elhossiny, Ian M. Loveless, Padma Kadiyala, Monica E. Bonilla, Emily L. Lasse Opsahl, Carinna Solano Vargas, Katelyn L. Donahue, Samantha B. Kemp et al. · 2025 · iScience
Integrative multi-omics analysis and experimental validation identify molecular subtypes, prognostic signature, and CA9 as a therapeutic target in oral squamous cell carcinoma
Yun Zhao, Jing Yang, Yamei Jiang, Jing‐biao Wu · 2025 · Frontiers in Cell and Developmental Biology
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions
Chengwei Peng, Paul E. Oberstein · 2025 · Current Treatment Options in Oncology
Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids
Sabrina T. Hirshorn, Nina G. Steele, Yana L. Zavros · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting
Nardeen Perko, Shaker A. Mousa · 2022 · Cancers
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Nebojša Skorupan, Shadin Ghabra, Jose Alberto Maldonado, Yang Zhang, Christine Alewine · 2023 · Journal of Cancer Metastasis and Treatment
Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer
Yangdong Wu, Qingyan Kou, Lin Sun, Xiao Hu · 2023 · Scientific Reports
BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer
Wenxin Qi, Qian Liu, Wenjun Fu, Jiaming Shi, Minmin Shi, Songqi Duan, Zhe Li, Shaohua Song, Jiao Wang, Yihao Liu · 2023 · Scientific Reports
Meta-analysis of fish consumption and risk of pancreatic cancer in 13 prospective studies with 1.8 million participants
Wei Jiang, Min Wang, Haizhong Jiang, Guo‐Chong Chen, Yongfei Hua · 2019 · PLoS ONE
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer
Lívia Archibugi, Sabrina Gloria Giulia Testoni, Miriam Redegalli, Maria Chiara Petrone, Michele Reni, Massimo Falconi, Claudio Doglioni, Gabriele Capurso, Paolo Giorgio Arcidiacono · 2019 · World Journal of Gastrointestinal Oncology
Identification and Development of Long Non‐coding RNA Associated Regulatory Network in Pancreatic Adenocarcinoma
Wenjuan Zhu, Wenzhe Gao, Yanyao Deng, Xiao Yu, Hongwei Zhu · 2020 · OncoTargets and Therapy
An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
Zengyu Feng, Kexian Li, Jianyao Lou, Yulian Wu, Chenghong Peng · 2021 · Frontiers in Cell and Developmental Biology
Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer
Libin Song, Simin Qi, Wei Hu, Zhixiao Fang, Dehua Yu, Teng Liu, Jingni Wu, Yangjun Wu, Aiwei Wu, Lanyun Feng et al. · 2021 · Molecular Therapy — Nucleic Acids
Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer
Kun Fang, Hairong Qu, Jiapei Wang, Desheng Tang, Changsheng Yan, Jiamin Ma, Lei Gao · 2021 · Frontiers in Genetics
Synthetic Conjugated Oligoelectrolytes Are Effective siRNA Transfection Carriers: Relevance to Pancreatic Cancer Gene Therapy
Chengbin Yang, Haoqiang Huang, Rajinder Singh Kaler, Cheng Yu Zhou, Guang Yu Yang, Zhourui Xu, Haoming Lin, Gaixia Xu, Ken‐Tye Yong, Guillermo Carlos Bazan · 2022 · Biomacromolecules
Molecular Pathology of Pancreatic Cancer
Eva Karamitopoulou · 2022 · Cancers
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
Ahmad Hassan Ali, Ugo Chianese, Chiara Papulino, Antonella Toraldo, Mawada Elmagboul Abdalla Abakar, Eugenia Passaro, Rosario Cennamo, Nunzio Del Gaudio, Lucia Altucci, Rosaria Benedetti · 2022 · Cancers
Discriminative Subtyping of Lung Cancers from Histopathology Images via Contextual Deep Learning
Benjamin J. Lengerich, Maruan Al-Shedivat, Amir Alavi, Jennifer A. Williams, Sami Labbaki, Eric P. Xing · 2020 · medRxiv
Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer
Chin-King Looi, Li-Lian Gan, Wynne Sim, Ling‐Wei Hii, Felicia Fei‐Lei Chung, Chee‐Onn Leong, Wei‐Meng Lim, Chun‐Wai Mai · 2022 · Cancers
Studying the impact of marital status on diagnosis and survival prediction in pancreatic ductal carcinoma using machine learning methods
Qingquan Chen, Yiming Hu, Wen C. Lin, Zhimin Huang, Jiaxin Li, Haibin Lu, Rongrong Dai, Liuxia You · 2024 · Scientific Reports
Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma
Yu Li, Miaoxuan Chen, Haitao Li, Xiao-ming Cai, Bo Chen, Zefeng Xie · 2024 · Open Medicine
Efficacy and safety of first-line chemotherapies for patients with advanced pancreatic ductal adenocarcinoma: A systematic review and network meta-analysis
Mao-Ji Kang, Haoxin Li, Yu Gan, Cheng Fang, Xiao-Li Yang, Bo Li, Song Su · 2024 · Heliyon
mCAUSE: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes
Daisuke Murata, Fumiya Ito, Gongyu Tang, Wakiko Iwata, Nelson Yeung, Junior J. West, Andrew J. Ewald, Xiaowei Wang, Miho Iijima, Hiromi Sesaki · 2024 · iScience
Gremlin1: a BMP antagonist with therapeutic potential in Oncology
Jin Zhao, Yanshuo Cao · 2024 · Investigational New Drugs